Wolverine Asset Management LLC Lexicon Pharmaceuticals, Inc. Transaction History
Wolverine Asset Management LLC
- $4.03 Billion
- Q1 2025
A detailed history of Wolverine Asset Management LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Wolverine Asset Management LLC holds 20,700 shares of LXRX stock, worth $13,248. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,700Holding current value
$13,248% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding LXRX
# of Institutions
135Shares Held
196MCall Options Held
310KPut Options Held
77.3K-
Artal Group S.A. Luxembourg, N4136MShares$87.2 Million100.0% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$6.33 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.56MShares$6.12 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.21MShares$5.26 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA3.69MShares$2.36 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $121M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...